Page last updated: 2024-10-24

candesartan and Dyspnea

candesartan has been researched along with Dyspnea in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Dyspnea: Difficult or labored breathing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wada, Y1
Kobayashi, D1
Murakami, S1
Oda, M1
Hanawa, H1
Kuroda, T1
Nakano, M1
Narita, I1

Other Studies

1 other study available for candesartan and Dyspnea

ArticleYear
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
    Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:5

    Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazo

2011